Small molecule inhibitors for the treatment or prevention of dengue virus infection

Abstract

Methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by flavivinis is disclosed, i.e., including but not limited to, Dengue virus, West Nile virus, yellow fever virus, Japanese encephalitis virus, and tick-borne encephalitis virus.

1 . A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound having the following general Formula I or a pharmaceutically acceptable salt thereof: 
       
         
           
           
               
               
           
         
         wherein A is N or C—R 5  and B is N or C—R 6 , wherein R 5  and R 6  are independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, hydroxy, alkyloxy, aryloxy, heteroaryloxy, acyloxy, arylacyloxy, heteroarylacyloxy, alkylsulfonyloxy, arylsulfonyloxy, thio, alkylthio, arylthio, amino, alkylammo, dialkylammo, cycloalkylamino, heterocycloalkylamino, arylammo, heteroarylamino, acylamino, arylacylamino, heteroarylacylamino, alkylsulfonylamino, arylsulfonylamino, acyl, arylacyl, heteroarylacyl, alkylsulflnyl, arylsulflnyl, heteroarylsulfinyl, hydroxysulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aminosulfonyl, substituted aminosulfonyl, carboxy, alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, carbamoyl, substituted carbamoyl, halogen, cyano, isocyano, and nitro, or optionally R 5  and R 6  together with the carbons they are attached to form a substituted or unsubstituted ring, which may be aromatic or non-aromatic and optionally includes one or more heteroatoms in the ring and is optionally is fused with an aromatic or aliphatic ring; 
         X, Y and Z are independently selected from the group consisting of O, S and N—R 7 , wherein R 7  is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, acyl, arylacyl, heteroarylacyl, sulfonyl, aminosulfonyl, substituted aminosulfonyl, alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, carbamoyl, and substituted carbamoyl; 
         R 1  and R 2  are independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, alkyloxy, aryloxy, heteroaryloxy, acyloxy, arylacyloxy, heteroarylacyloxy, alkylsulfonyloxy, arylsulfonyloxy, alkylthio, arylthio, alkylammo, dialkylammo, cycloalkylammo, heterocycloalkylamino, arylammo, heteroarylamino, acylamino, arylacylammo, heteroarylacylamino, alkylsulfonylammo, arylsulfonylamino, acyl, arylacyl, heteroarylacyl, alkylsulflnyl, arylsulflnyl, heteroarylsulfinyl, hydroxysulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aminosulfonyl, substituted aminosulfonyl, carboxy, alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, carbamoyl, substituted carbamoyl, cyano, isocyano, and nitro, or optionally R 1  and R 2  together with the carbon they are attached to may form a substituted or unsubstituted ring, which optionally includes one or more heteroatoms in the ring and optionally is fused with an aromatic or aliphatic ring; 
         R 3  and R 4  are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, acyl, arylacyl, heteroarylacyl, alkylsulflnyl, arylsulfinyl, heteroarylsulfinyl, hydroxysulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aminosulfonyl, substituted aminosulfonyl, alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, carbamoyl, and substituted carbamoyl, or optionally R 3  and R 4  together with the nitrogen atom they are attached to form a substituted or unsubstituted ring, which optionally includes one or more heteroatoms in the ring and optionally is fused with an aromatic or aliphatic ring; and 
         R 1  or R 2  and R 3 or R 4 together with the carbon or nitrogen they are attached to and the carbon that Z is attached to optionally form a substituted or unsubstituted ring, which optionally includes one or more heteroatoms in the ring. 
       
     
     
         2 . The composition of  claim 1 , wherein each of R 1  and R 2  is hydrogen. 
     
     
         3 . The composition of  claim 1 , wherein Y is sulfur. 
     
     
         4 . The composition of  claim 1 , wherein said Z is oxygen. 
     
     
         5 . The composition of  claim 1 , wherein R 3 and R 4  together with the nitrogen atom they are attached to form a substituted ring. 
     
     
         6 . The composition of  claim 1 , wherein the compound of Formula I is selected from the group consisting of: N-[2-(2-Morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-3-phenyl-propionamide; N-[2-(2-Oxo-2-piperidin-1-yl-ethylsulfanyl)-benzothiazol-6-yl]-propionamide; 1′-[2-(Benzooxazol-2-ylsulfanyl)-acetyl]-[1,4′]bipiperidinyl-4′-carboxylic acid amide; 3-(Benzothiazol-2-ylsulfanyl)-1-benzyl-pyrrolidine-2, 5-dione; 2-Methyl-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 2, 4-Dichloro-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 1-(3,4-Dihydro-1H-isoquinolin-2-yl)-2-(6-ethoxy-benzothiazol-2-ylsulfanyl)-ethanone; 2-(1H-Benzoimidazol-2-ylsulfanyl)-1-[4-(4-fluoro-phenyl)-piperazin-1-yl]-ethanone; 1′-[2-(Benzothiazol-2-ylsulfanyl)-acetyl]-[1,4′]bipiperidinyl-4′-carboxylic acid amide; 2-(6-Ammo-benzothiazol-2-ylsulfanyl)-1-(4-benzyl-piperazm-1-yl)-ethanone; 2-(Benzooxazol-2-ylsulfanyl)-1-(4-benzyl-piperazin-1-yl)-ethanone; 1-[3-(2-Methoxy-benzoyl)-piperidin-1-yl]-2-(5-methyl-1H-benzoimidazol-2-ylsulfanyl)-ethanone; 3-Methyl-N-[2-(2-morpholm-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 2-(6-Ethoxy-benzothiazol-2-ylsulfanyl)-1-(4-phenyl-piperazin-1-yl)-ethanone; 2-Diethylcarbamoylmethylsulfanyl-benzoimidazole-1-carboxylic acid cyclohexylamide; 2-(6-Ammo-benzothiazol-2-ylsulfanyl)-1-morpholin-4-yl-ethanone; 2-(6-{[1-(4-Bromo-phenyl)-meth-(E)-ylidene]-amino}-benzothiazol-2-ylsulfanyl)-1-morpholm-4-yl-ethanone; 2-(6-{[1-(4-Chloro-phenyl)-meth-(E)-ylidene]-amino}-benzothiazol-2-ylsulfanyl)-1-morpholm-4-yl-ethanone; 2-(6-{[1-Anthracen-9-yl-meth-(E)-ylidene]-amino}-benzothiazol-2-ylsulfanyl)-1-morpholm-4-yl-ethanone; 2-Bromo-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; N-[2-(2-Morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 4-Butoxy-N-[2-(2-morpholm-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 1-Morpholin-4-yl-2-(6-{[1-[5-(1-phenyl-1H-tetrazol-5-ylsulfanyl)-furan-2-yl]-meth-(E)-ylidene]-amino}-benzothiazol-2-ylsulfanyl)-ethanone; 2-(6-{[1-(2,6-Dichloro-phenyl)-meth-(E)-ylidene]-amino}-benzothiazol-2-ylsulfanyl)-1-morpholin-4-yl-ethanone; 2-(6-{[1-(4-Iodo-phenyl)-meth-(E)-ylidene]-amino}-benzothiazol-2-ylsulfanyl)-1-morpholin-4-yl-ethanone; 2-(6-{[-(4-Fluoro-phenyl)-meth-(E)-ylidene]-amino}-benzothiazol-2-ylsulfanyl)-1-morpholin-4-yl-ethanone; 2-Fluoro-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 2-Methoxy-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 3,4-Dichloro-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 2-[6-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-benzothiazol-2-ylsulfanyl]-N,N-diethyl-acetamide; 2-(6-Amino-benzothiazol-2-ylsulfanyl)-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-acetamide; Cyclohexanecarboxylic acid [2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-amide; 2-(1-Methyl-1H-imidazol-2-ylsulfanyl)-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-acetamide; 2-(Benzothiazol-2-ylsulfanyl)-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-acetamide; 2-(4,5-Diphenyl-4H-[1, 2,4]triazol-3-ylsulfanyl)-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-acetamide; 2-(4-Methyl-5-naphthalen-1-ylmethyl-4H-[1,2,4]triazol-3-ylsulfanyl)-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-acetamide; 2-(4-Methyl-5-phenyl-4H-[1,2,4]triazol-3-ylsulfanyl)-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-acetamide; N-[2-(2-Morpholm-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-2-naphthalen-1-yl-acetamide; 1-(4-Benzothiazol-2-yl-piperazin-1-yl)-2-(6-ethoxy-benzothiazol-2-ylsulfanyl)-ethanone; 2-(6-Amino-benzothiazol-2-ylsulfanyl)-1-(4-benzothiazol-2-yl-piperazin-1-yl)-ethanone; 2-(Benzothiazol-2-ylsulfanyl)-1-piperidin-1-yl-ethanone; 2-(1H-Benzoimidazol-2-ylsulfanyl)-1-morpholin-4-yl-ethanone; 1-Azepan-1-yl-2-(1H-benzoimidazol-2-ylsulfanyl)-ethanone; 2-(IH-Benzoimidazol-2-ylsulfanyl)-1-(4-methyl-piperidin-1-yl)-ethanone; 2-(1H-Benzoimidazol-2-ylsulfanyl)-1-pyrrolidin-1-yl-ethanone; 2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(4-phenyl-piperazin-1-yl) -ethanone; 2-(Benzooxazol-2-ylsulfanyl)-1-(3, 4-dihydro-1H-isoquinolin-2-yl)-ethanone; 2-(2-oxo-2-piperidin-1-yl-ethylsulfanyl)-benzooxazole-5-carboxylic acid; 2-(6-Nitro-benzothiazol-2-ylsulfanyl)-1-piperidin-1-yl-ethanone; 1-(4-Benzothiazol-2-yl-piperazin-1-yl)-2-(benzothiazol-2-ylsulfanyl)-ethanone; 2-(1-Phenyl-1H-benzoimidazol-2-ylsulfanyl)-1-(4-phenyl-piperazin-1-yl)-ethanone; 2-(6-Nitro-benzothiazol-2-ylsulfanyl)-1-(4-phenyl-piperazin-1-yl)-ethanone; 2-[5-(Benzothiazol-2-ylsulfanylmethyl)-[1,3,4]oxadiazol-2-ylsulfanyl]-N-cyclohexyl-acetamide; N-{2-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethylsulfanyl]-benzothiazol-6-yl}-propionamide; 2-(6-Nitro-benzothiazol-2-ylsulfanyl)-1-pyrrolidin-1-yl-ethanone; 4-Methyl-N-[2-(2-oxo-2-piperidin-1-yl-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; N-{2-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethylsulfanyl]-benzothiazol-6-yl}-acetamide; 4-Chloro-N-[2-(2-oxo-2-pyrrolidin-1-yl-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 2-(6-Amino-benzothiazol-2-ylsulfanyl)-1-pyrrolidm-1-yl-ethanone; 3-(4-Benzothiazol-2-yl-piperazin-1-yl)-1-(4-fluoro-phenyl)-pyrrolidine-2, 5-dione; 2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3,4-dihydro-1H-isoquinolm-2-yl)-ethanone; N, N-Diethyl-2-(5-methyl-1H-benzoimidazol-2-ylsulfanyl)-acetamide; 2-(Benzothiazol-2-ylsulfanyl)-1-pyrrolidin-1-yl-ethanone; 3,4-Dimethoxy-N-[2-(2-morpholin-4-yl-2-oxo-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 2-Bromo-N-[2-(2-oxo-2-pyrrolidm-1-yl-ethylsulfanyl)-benzothiazol-6-yl]-benzamide; 1-[2-(Benzothiazol-2-ylsulfanyl)-acetyl]-piperidine-4-carboxylic acid amide; 1-[2-(Benzooxazol-2-ylsulfanyl)-acetyl]-piperidine-4-carboxylic acid amide; 1-[2-(1H-Benzoimidazol-2-ylsulfanyl)-acetyl]-piperidine-4-carboxylic acid amide; 1′-[2-(4-Ethyl-5-phenyl-4H-[1,2,4]triazol-3-ylsulfanyl)-acetyl]-[1,4′]bipiperidinyl-4′-carboxylic acid amide; 1′-[2-(1H-Benzoimidazol-2-ylsulfanyl)-acetyl]-[1, 4′]bipiperidmyl-4′-carboxylic acid amide; 2-(Benzothiazol-2-ylsulfanyl)-1-[4-(4-fluoro-phenyl)-piperazin-1-yl]-ethanone; 1-(4-Benzhydryl-piperazin-1-yl)-2-(benzothiazol-2-ylsulfanyl)-ethanone; 1-[4-(3-Chloro-phenyl)-piperazin-1-yl]-2-(6-nitro-benzothiazol-2-ylsulfanyl)-ethanone; 2-(5-Chloro-benzooxazol-2-ylsulfanyl)-1-morpholm-4-yl-ethanone; N-{2-[2-0x0-2-(4-phenyl-piperazin-1-yl)-ethylsulfanyl]-benzothiazol-6-yl}-butyramide; 2-(Benzooxazol-2-ylsulfanyl)-1-(4-phenyl-piperazm-1-yl)-ethanone; 2-(6-Ammo-benzothiazol-2-ylsulfanyl)-1-[4-(4-chloro-phenyl)-piperazm-1-yl]-ethanone; 2-(Benzooxazol-2-ylsulfanyl)-1-[4-(4-p-tolyl-phthalazin-1-yl)-piperazin-1-yl]-ethanone; 2-{1-[(2,6-Dimethyl-phenylcarbamoyl)-methyl]-1H-benzoimidazol-2-ylsulfanyl}-acetamide; 2-(Benzooxazol-2-ylsulfanyl)-1-[4-(4-chloro-phenyl)-piperazin-1-yl]-ethanone; 1-(3, 4-Dihydro-1H-isoquinolm-2-yl)-2-(1-methyl-1H-benzoimidazol-2-ylsulfanyl)-ethanone; and 2-(1-Benzenesulfonyl-1H-benzoimidazol-2-ylsulfanyl)-1-pyrrolidin-1-yl-ethanone. 
     
     
         7 . The composition of  claim 6 , wherein the compound of Formula I is 1′-[2-(Benzooxazol-2-ylsulfanyl)-acetyl]-[1,4′]bipiperidmyl-4′-carboxylic acid amide. 
     
     
         8 - 26 . (canceled)